VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
LY103 — World's First Marine Drug for Sepsis-Induced Coagulopathy Receives Clinical Trial Approval
LY103 — World's First Marine Drug for Sepsis-Induced Coagulopathy Receives Clinical Trial Approval
May 18, 2026 18:05 CST Updated May 19, 10:29
Share:
